Cargando…
Trametinib: Could It Be a Promising Drug to Treat Atypical Chronic Myeloid Leukemia?
Atypical chronic myeloid leukemia (aCML) is a rare disease that is currently classified under the myelodysplastic (MDS)/myeloproliferative neoplasm (MPN) disease spectrum. MDS/MPN diseases are characterized by the absence of the Philadelphia (Ph) chromosome and the overlap between bone marrow fibros...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356656/ https://www.ncbi.nlm.nih.gov/pubmed/35949766 http://dx.doi.org/10.7759/cureus.26619 |